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ABSTRACT
Two cases of severe bovine papillomatosis occurred in northwest Croatia during 2000 are described. 
Diagnosis was based on presented clinical signs, histopathological findings, and detection of the papillomavirus 
by transmission electron microscopy. Animals successfully recovered following treatment with the autogenous 
(non-purified) vaccine and a parammunity inducer. For the first time in Croatia we report the detection of 
papillomavirus by electron microscopy.
Key words: bovine papillomavirus, transmission electron microscopy, autogenous vaccine, parammunity 
inducer
Introduction
Bovine papillomatosis is a common viral disease of the skin, mostly of young cattle, 
manifested as benign tumours or warts, caused by bovine papillomavirus (BPV) that has 
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six serotypes hitherto described (OLSON, 1990).  These neoplasms most often regress 
spontaneously, occasionally persist, and, in the presence of additional critical genetic 
or environmental factors, can progress to cancer (CAMPO, 1987). It is thought to be a 
multistep affair (KOLLER and OLSON, 1972; LANCASTER and OLSON, 1982).  Furthermore, 
papillomavirus infection in cattle could be connected with serious disorders of the metabolism 
(mainly mineral, energetic and nitrous) probably caused by damage of the liver and kidney 
with mutagenic, carcinogenic and immunosuppressive cadmium, arsenic and lead, observed 
in the serum of tested animals (LESNIK et al., 1999). Infection by BPV occurs as a result of 
the virus exposure to single or multiple lesions of the epithelium. Papillomaviral infection, 
transformation and multiplication of basal cells, lead to wart formation, but most warts are 
benign and do not proliferate indefinitely (SHAH and HOWLEY, 1996). Different methods 
have been used to treat bovine papillomas. A formalinized suspension of bovine warts 
with inactivated virus provides a vaccine for effective treatment and prophylaxis of bovine 
papillomatosis (BARTHOLD et al., 1976; HUNT, 1984; LESNIK et al., 1999; SÜVEGES and 
SCHMIDT, 2003). Intra-lesional immunotherapy by Corynebacterium parvum has also 
been reported (HALL et al., 1994). There are no reports about combined therapy of bovine 
papillomatosis using the autogenous vaccine and a parammunity inducer.
Although numerous cases of bovine papillomatosis have occurred in Croatia over past 
years, written data regarding diagnosis and treatment are still scarce. Thus, in order to 
obtain a better insight into bovine papillomatosis, we report here on severe cases recently 
observed in Croatia, detection of BPV by transmission electron microscopy, treatment with 
the autogenous vaccine and a parammunity inducer, and clinical recovery of animals.
Materials and methods
Animals. Two cases of severe bovine papillomatosis occurred in northwest Croatia 
during 2000 are described. The first case was registered in a 15-month-old Holstein heifer 
suffering from severe generalized papillomatosis with multiple papillomas, from 0.5 to 
50 mm in diameter, disseminated on the ears, head, neck, shoulders, abdomen, udder and 
perigenitaly. The warts on the abdomen had a cauliflower-like appearance, strongly attached 
to the dermis (Fig. 3). The second case was registered in a 4-year-old dairy Simmental cow 
with multiple papillomas (from 0.5 to 30 mm) on the head, neck, shoulder and udder.
The diagnosis of bovine papillomatosis was arrived at on the basis of presented 
clinical signs, since the structure of the papillomas on the skin was easily observed and 
identified. However, a few papillomas from each animal were surgically removed in order 
to confirm the diagnosis by histopathology, and for the preparation of an autogenous 
vaccine. Furthermore, the tumours were taken in order to detect BPV by transmission 
electron microscopy in supernatant of dissected homogenized tissue. 
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Histopathology. Surgically obtained tissue samples were immediately immersed in 
10% formalin at room temperature for at least 48 h before processing. Fixed specimens 
were dehydrated through graded alcohols and embedded in paraffin wax; 6 µm-thick serial 
sections were cut, stained with haematoxylin and eosin (HE), and examined with a light 
microscope equipped with an ocular micrometer (Nikon Eclipse E600, Japan).
Electron microscopy. Tissue samples were prepared for electron microscopy by the 
negative staining technique. Pelleted viral particles were resuspended in distilled water 
and a drop of viral suspension was placed on a Petri dish. A Formvar-coated electron 
microscopy (EM) grid was placed Formvar side down on top of the virus drop for 
approximately 1-3 minutes. The grid was removed, blotted with filter paper and placed 
onto a drop of 2.0% phosphotungstic acid (PTA), pH 7.0, for one minute. The excess PTA 
was removed, and the EM grid was ready for viewing in the Zeiss EM 10A transmission 
electronic microscope. 
Autogenous vaccine preparing and treatment of animals. The autogenous vaccine was 
prepared according to laboratory protocol reported previously by HUNT (1984). The animals 
were treated by autogenous vaccine administered in doses of 0.5 ml i/c and 10 ml s/c, and 
twice revaccinated at 10-day intervals. Prior to vaccination, as a parammunity inducer, on 
each occasion the immunomodulator (Baypamun®, Bayer Pharma, Leverkusen, Germany) 
was administered in doses of 2 ml s/c.
Results
Diagnosis was based on presented clinical signs, histopathological findings, and 
detection of the papillomavirus by transmission electron microscopy. Grossly, tumour tissue 
was composed of hyperplastic epidermis supported by thin, inconspicuous dermal stalks. In 
both cases histopathology revealed fibropapillomatosis with acanthosis, hyperkeratosis and 
down-growth of rete ridges. The virus appears to infect the basal cells of the epithelium, 
causing hyperplasia with hydropic ballooning of their cytoplasms, large eosinophilic 
keratohyaline granules and vesicular nuclei. Some cells degenerated, while others were 
stimulated to excessive growth and formation of warts (Fig. 1). 
Electron microscopy examination of tumour tissue by the negative staining technique 
demonstrated virions that were very similar to BPV (Fig. 2). The diameter of the virions 
measured approximately 60 nm. The typical papillomavirus virions are composed of 
capsomeres arranged in icosaedral symmetry of the capside. Only sporadic virions were 
found in the hyperkeratotic surface layer, while large clusters were formed in the deep 
layers. Both solitary destroyed and corelless particles with electrondense core space were 
present in the aggregates. 
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The animals were treated successfully by autogenous vaccine and an immunomodulator. 
Regression (Fig. 3 and Fig. 4) of papillomas in both cases occurred about 3 weeks after the 
beginning of treatment, and within 6 weeks all warts spontaneously disappeared and animals 
completely recovered. No recurrence of papillomas has been observed in treated cows.
Discussion
Although bovine papillomatosis is a self-limiting disease the animals in our study have 
long lasting multiple papillomas without any sign of regression within months. The clinical 
diagnosis was confirmed by histopathology findings and detection of BPV in tumour tissue 
Fig. 3. Multiple papillomas in Holstein heifer 
disseminated on the abdomen, measuring from 
0.5 to 50 mm.
Fig. 4. Complete regression of papillomas 6 
weeks after the beginning of treatment.
Fig. 2. Transmission electron micrograph 
of negatively stained tissue homogenizatum 
shows cluster of BPV. Arrow shows one virion 
measuring approximately 60 nm.
Fig. 1. Histopathological section of a wart tissue 
stained with HE
N.  Turk et al.: Severe bovine papillomatosis
395Vet. arhiv 75 (5), 391-397, 2005
by transmission electron microscopy. For the first time in Croatia, we report the detection 
of papillomavirus by electron microscopy.
The autogenous vaccine and a parammunity inducer (Baypamun®, Bayer Pharma, 
Leverkusen, Germany) were used for treatment of animals. Reports of bovine papillomatosis 
treatment with vaccine produced from formalinized suspension of wart tissue indicate 
variable results. LESNIK et al. (1999) reported that treatment with vaccine showed 93.5% 
efficiency with no difference in the used vaccine after 105 days of vaccination. SÜVEGES 
and SCHMIDT (2003) showed autogenous vaccination made from sterile homogenized 
tumour tissue and, performed twice, prevented new cases and with sick animals recovering 
after vaccination. On the contrary, treatment with autogenous wart vaccine sometimes 
failed (SMITH, 1990). Commercial vaccines for cattle rarely seem to effectively promote 
regression of existing warts or to prevent malignant progression, although they may be 
capable of preventing the development of new lesions if the same strain is involved 
(SMITH, 1990; CAMPO, 1991; SCOTT and ANDERSON, 1992). As shown in several in 
vivo studies, the stimulation of endogenous, non-antigen related defence mechanisms by 
parapoxvirus-based immunomodulators opens up new possibilities for the control and 
treatment of infectious diseases in domestic animals (STRUBE et al., 1989; ZIEBELL et al., 
1997; CASTRUCCI et al., 1998; KYRIAKIS et al., 1998; GLITZ, 2002). Inactivated parapox 
ovis viruses, due to their complex genetic structure and thereby their strong immunogenic 
properties, induce host immune reaction. There is growing evidence that such immune 
reactions may result in more than elimination of the virus (FACHINGER et al., 2000). Our 
results showed the efficacy of bovine papillomatosis treatment with the autogenous vaccine 
and a parammunity inducer in the manner of earlier regression of papillomas. Data reported 
previously based on the treatment only with autogenous vaccine showed a longer period 
necessary for animal recovery then we obtained (SCOT and ANDERSON, 1992; LESNIK et 
al., 1999). Additionally, we consider that our treatment could be appropriate in the early 
stage of disease (growing stage of warts) when surgical intervention is contraindicated 
due to the possibility of recurrence of papillomas. Although we treated only two animals 
in that manner, we believe that a parammunity inducer also shows a beneficial effect in 
additional treatment of bovine papillomatosis. However, our hypothesis needs to be clarified 
and proved in further studies. We consider that it is important to compare reports of new 
cases to obtain a better insight into the aetiology, pathogenesis and different methods of 
treatment. Furthermore, molecular epizootiology of BPV viruses circulating in Croatia 
remains to be investigated in the future. 
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SAŽETAK
U radu su opisana dva slučaja generalizirane papilomatoze u goveda ustanovljena u sjeveroistočnom 
području Republike Hrvatske tijekom 2000. godine. U oba slučaja dijagnoza je postavljena na osnovi kliničke 
slike, histopatološke pretrage tumorskog tkiva i nalaza papilomavirusa goveda u homogenizatu tumorskog tkiva 
elektronskom mikroskopijom. Životinje su liječene autogenom vakcinom i imunomodulatorom (Baypamun®, 
Bayer Pharma, Leverkusen, Germany), a tumorozne promjene u potpunosti su iščezle nakon 6 tjedana od početka 
liječenja. U radu je po prvi put u Republici Hrvatskoj opisan nalaz papilomavirusa goveda u tumorskom tkivu 
elektronskom mikroskopijom.
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